- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Ripharma Laboratories Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (93), financial health (95), director (45) and company-foundation signals.
- Operating for 11+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2025.
- Positive net worth.
- 6 directors on the board.
- Director SHANTILAL RAJMAL JAIN has DIN status "Disqualified by RoC u/s 164(2)".
About Ripharma Laboratories Limited
Ripharma Laboratories Limited is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24100MH2015PLC262970). Business overview includes Pharma (Drug Formulation & Development), incorporated on March 25, 2015 (11+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status.
- Location 144, Behram Mahal,534, Kalbadevi Road, Near Edward Cinema, Mumbai, Maharashtra - 400002
- Website ripharma.in
Financial Performance of Ripharma Laboratories Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Ripharma Laboratories Limited (6)
Charges of Ripharma Laboratories Limited
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 23 Jan 2025 |
4.90 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Trade | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
